InvestorsHub Logo
icon url

plexrec

04/14/22 6:01 PM

#357318 RE: falconer66a #357316

" blarcamesine will be granted sales and therapeutic use authorizations."--exactly on why I am still invested here--will be 7 years this coming May--finish line getting closer !!!! IMO "wunder drug'" for CNS illnesses---Autism Spectrum and more...... Hold your shares !!!!!!!
icon url

abew4me

04/14/22 6:03 PM

#357319 RE: falconer66a #357316

Excellent post. Thanks for your summarization, falconer.
icon url

rayovacAAA

04/14/22 6:11 PM

#357320 RE: falconer66a #357316

PURE B.S.!!!!!!!!!!!


In every one of the several clinical trials of blarcamesine (Anavex 2-73) aimed at central nervous system (CNS) diseases, no adverse events (AEs), side effects.

icon url

Amatuer17

04/15/22 7:19 AM

#357347 RE: falconer66a #357316

Hope your dream comes true

“ Which means that I’ll never be selling a share of my AVXL position. I’m in my mid-70s. I’ll be rewarded in a few years with Anavex dividends. The shares will pass to my estate’s beneficiaries and to the philanthropies I will designate”

You will know if this remains dream or not in less than 9 months. There is higher chances that you don’t have to sell AVXL shares but will be forced to sell to book losses as the AD trial results may not be as good or will not show efficacy (like so many AD trials)